Standard Kidney Function Tests Underestimate Chronic Kidney Disease in People with Cancer
4 Articles
4 Articles
Common kidney tests underestimate chronic kidney disease in cancer patients
New research indicates that commonly used measures of kidney function largely underestimate the prevalence of chronic kidney disease (CKD) in patients with cancer. The findings will be presented at ASN Kidney Week 2026 October 22–25.
Standard kidney function tests underestimate chronic kidney disease in people with cancer
New research indicates that commonly used measures of kidney function underestimate the prevalence of chronic kidney disease (CKD) in patients with cancer. The findings will be presented at ASN Kidney Week 2026, Oct. 22–25.
BIOENGINEER.ORG
Scienmag: Latest Science and Health NewsStandard kidney function tests underestimate chronic kidney disease in
A study of 1,200 adults with solid tumors presented at ASN Kidney Week 2026 found that creatinine-based and creatinine-plus-cystatin-C estimates of glomerular filtration rate substantially undercount chronic kidney disease compared with directly measured GFR, raising concerns about anticancer drug eligibility and dosing.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
